RBR-7b5hhk已完成1 期
In vivo evaluation and monitoring with nanosensors effect hypoglycemic of cucurbita ficifolia Bouché in type 2 diabetic patients
Embrapa Hortaliças0 个研究点开始时间: 2016年8月23日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Intervention
入排标准
- 年龄范围
- 35Y 至 65Y（—）
入选标准
- •Individuals diagnosed with pre-diabetes (> 100 to < 125 mg/dL) and individuals diagnosed with type 2 diabetes mellitus (> 126 to < 300 mg/dL).
排除标准
- •Individuals diagnosed with Type 2 diabetes for over 6 months with blood glucose > 300 mg/dL.
研究者
相似试验
进行中（未招募）
不适用
Nanochip Technology in Monitoring Treatment Response and Detecting Relapse in Participants With Diffuse Large B-Cell LymphomaDiffuse Large B-Cell LymphomaDiffuse Large B-Cell Lymphoma Germinal Center B-Cell TypeDiffuse Large B-Cell Lymphoma, Not Otherwise SpecifiedHigh Grade B-Cell LymphomaNCT03656835Ohio State University Comprehensive Cancer Center73
已完成
不适用
Feasibility and Accuracy of Nanosensor-based Cancer Diagnosis at the Point-of-care (Chedza)Breast NeoplasmsLymphomaNCT04119154Harvard School of Public Health (HSPH)270
已完成
不适用
Real Time In-Vivo Body Surface Dosimetry for External Beam Radiation TherapyCancer of the Gastrointestinal, Genitourinary or Gynecologic SystemsNCT02407977Duke University13
招募中
Unknown
Preventing infusate injuries throughout a child’s hospitalisatioExtravasation injuries (caused by peripheral intravenous catheters of infants)Injuries and Accidents - Other injuries and accidentsACTRN12623000561684niversity of Queensland532
尚未招募
不适用
Validation study for rapid profiling of immunohistochemical markers for breast cancerCancerPACTR202111860919273Aikili Biosystems Inc.40